CVS Health (CVS) stock soared about 15% yesterday after posting upbeat fourth-quarter results, with revenues and earnings ...

Barclays analyst Andrew Mok CFA maintained a Buy rating on CVS Health (CVS – Research Report) today and set a price target of $73.00. The ...

Shares of CVS Health Corporation (NYSE: CVS) experienced a jolt, rising over 15% on February 12, 2025, as the market responded to the release of its fourth-quarter 2024 earnings report. CVS Health's ...

CVS Health beat Wall Street estimates for fourth-quarter profit on Wednesday and provided an annual forecast that largely met ...

Feb 12 (Reuters) - CVS Health (CVS.N), opens new tab reported ... conglomerate and revenues jumped in its pharmacy business. The company missed earnings targets for the first three quarters ...

For the second day in a row, CVS Health's (NYSE: CVS) stock price saw a satisfying jump on Thursday. The company squeaked past the consensus analyst estimate for revenue, and crushed that for non ...

CVS Health reported $4.6 billion in 2024 profits including $1.6 billion in the fourth quarter as the company worked to overcome rising medical expenses from patients in its health insurance business.

Analysts polled by FactSet expect $5.86 per share. CVS Health is trying to move past a rough 2024 in which the company cut its forecast several times and saw its stock price tumble about 43%.

Copyright © 2025 MarketWatch, Inc. All rights reserved.

Huh, file) Updated [hour]:[minute] [AMPM] [timezone], [monthFull] [day], [year] CVS Health steered through rising costs in its insurance division to handily beat profit expectations on Wall Street.

CVS Health steered through rising costs in its insurance division to handily beat profit expectations on Wall Street.